Certificate number:RU.77.99.88.003.Е.004591.10.17
Date of registration and renewal:30.10.2017
Dosage form: & nbspCapsules "Day (Day)" for 450 mg, capsules "Night (Night)" for 355 mg.
Composition: & nbspCapsules "Day": raw food Dyglomera DYG-400-P (extract of dystochthysis), raw food Cissus CQR-300 (extract of cissus quadrangular),raw food IGOB 131 (extract of Irvine Gabonese), caffeine, raw food Lipofuel (extract of peppers), lemon balm extract, E460, E551, capsule shell (gelatin or E464, food color E171 or E100 or E101 or E160a, or E162, or E163, or E140 or E141 or E 132), the composition of the capsule shell of DRcapsTM (E464, E418, the food color E171 or E100 or E101, or E160a, or E162, or E163 or E140 or E141, or E 132).
Capsules "Night": raw food Dyglomera DYG-400-P (extract of dichro-stichis), raw food Cissus CQR-300 (extract of cissus quadrangular), raw food IGOB 131 (extract of Irving Gabonese), raw food Lipofuel (extract of chilli pepper ), heartwort extract, E460, E551, capsule shell (gelatin or E464, food color E171, or E100 or E101, or E160a, or E162, or E163, or E140 or E141 or E 132), the composition of the capsule shell DRcapsTM (E464, E418, food color E171, or E100, or E101, or E160a, or E162, or E163, or E140, or E141, or E 132).
Scope: & nbspFor sale to the public as a biologically active food additive - a source of phenolic compounds, caffeine containing capsaicin.
Suggested Usage: & nbspAdults before the meal for 1 capsule "Day (Day)" in the morning; 1 capsule "Night (Night)" in the afternoon. Duration of admission is 2-3 weeks.
Contraindications:Individual intolerance of the components of the product, pregnancy and lactation, increased nervous excitability, insomnia, high blood pressure, a violation of the rhythm of the heart activity, pronounced atherosclerosis. Before use, it is recommended to consult a doctor.
Special instructions:If necessary, the reception can be repeated after 1-2 months. Repeated receptions are possible throughout the year.
Shelf life:2 years.
Storage conditions:Store in a dry and inaccessible place for children at a temperature not exceeding + 25 ° C.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.88.003.Е.004304.10.17 of 03.10.2017; expert conclusion of the FGBM of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 3992 of September 29, 2017.
Recipient:Pharmaceutical holding GI EL Medical, OOOPharmaceutical holding GI EL Medical, OOO Russian Federation
Information update date: & nbsp17.01.2018
Instructions
Up